These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 24867391

  • 1. Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307.
    Krauss GL, Perucca E, Ben-Menachem E, Kwan P, Shih JJ, Clément JF, Wang X, Bagul M, Gee M, Zhu J, Squillacote D.
    Epilepsia; 2014 Jul; 55(7):1058-68. PubMed ID: 24867391
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
    French JA, Krauss GL, Steinhoff BJ, Squillacote D, Yang H, Kumar D, Laurenza A.
    Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.
    Steinhoff BJ, Ben-Menachem E, Ryvlin P, Shorvon S, Kramer L, Satlin A, Squillacote D, Yang H, Zhu J, Laurenza A.
    Epilepsia; 2013 Aug; 54(8):1481-9. PubMed ID: 23663001
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures.
    Ko D, Ramsay RE.
    Acta Neurol Scand Suppl; 2013 Aug; (197):36-43. PubMed ID: 23480155
    [Abstract] [Full Text] [Related]

  • 10. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
    Gidal BE, Ferry J, Majid O, Hussein Z.
    Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of perampanel in children and adults with various epilepsy syndromes: A single-center postmarketing study.
    Singh K, Shah YD, Luciano D, Friedman D, Devinsky O, Kothare SV.
    Epilepsy Behav; 2016 Aug; 61():41-45. PubMed ID: 27300147
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study.
    Rosenfeld W, Conry J, Lagae L, Rozentals G, Yang H, Fain R, Williams B, Kumar D, Zhu J, Laurenza A.
    Eur J Paediatr Neurol; 2015 Jul; 19(4):435-45. PubMed ID: 25823975
    [Abstract] [Full Text] [Related]

  • 13. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
    Strzelczyk A, Willems LM, Willig S, Rosenow F, Bauer S.
    Expert Rev Clin Pharmacol; 2015 Jul; 8(6):733-40. PubMed ID: 26436331
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
    Kwan P, Trinka E, Van Paesschen W, Rektor I, Johnson ME, Lu S.
    Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
    [Abstract] [Full Text] [Related]

  • 16. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study.
    Villanueva V, Garcés M, López-González FJ, Rodriguez-Osorio X, Toledo M, Salas-Puig J, González-Cuevas M, Campos D, Serratosa JM, González-Giráldez B, Mauri JA, Camacho JL, Suller A, Carreño M, Gómez JB, Montoya J, Rodríguez-Uranga J, Saiz-Diaz R, González-de la Aleja J, Castillo A, López-Trigo J, Poza JJ, Flores J, Querol R, Ojeda J, Giner P, Molins A, Esteve P, Baiges JJ.
    Epilepsy Res; 2016 Oct; 126():201-10. PubMed ID: 27521586
    [Abstract] [Full Text] [Related]

  • 17. Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety.
    Lagae L, Villanueva V, Meador KJ, Bagul M, Laurenza A, Kumar D, Yang H.
    Epilepsia; 2016 Jul; 57(7):1120-9. PubMed ID: 27221398
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.